Larry Michael Mertz - 04 Apr 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Technology Officer
Signature
/s/ David Patience, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
04 Apr 2024
Transactions value $
-$861
Form type
4
Filing time
05 Apr 2024, 16:29:20 UTC
Previous filing
06 Mar 2024
Next filing
10 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +2.87K +5.45% $0.00 55.4K 04 Apr 2024 Direct F1
transaction AXDX Common Stock Sale -$861 -978 -1.76% $0.88 54.5K 04 Apr 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -2.87K -40.01% $0.00 4.3K 04 Apr 2024 Common Stock 2.87K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 4, 2022, the reporting person was granted a total of 7,164 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

Remarks:

On July 11, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, proportionate adjustments were made to the number of shares of the issuer's common stock underlying its outstanding equity awards, warrants and convertible notes, as well as the exercise or conversion price, as applicable. The amounts reported herein (and to be reported in subsequent reports) have been adjusted to reflect the Reverse Stock Split.